|
| |  | | | | |  |  |
At DoseCueTM, the focus is on changing the product to suit the patient, rather than asking the patient to change to suit the product. The DoseCue approach is clinically proven to significantly increase patient compliance.
In 2009, DoseCue conducted a study at a retail pharmacy to determine whether patient compliance improved when oral-dose medications were dispensed in a DoseCue-equipped container.
Study Design: Thirty-five (35) patients were enrolled and randomized to a Control or a Study Group. All patients used an inactive container for Month 1 (Phase 1), at which time half were crossed-over to an active container (Study Group). Remaining patients continued use of the inactive container (Control Group). Twenty-four (24) patients completed the study.
* P=0.05; 95% Confidence Interval; ANOVA statistical analysis. DoseCue Clinical Study, 2009.
** Date and time of container open/close is electronically logged by DoseCue devices.
For additional information about the DoseCue study, please contact info@dosecue.com.
DoseCue™ — Simply Improving Patient Compliance TM
NOTE: Avarvistar and Sextant Pharmaceuticals are ficticious names for demonstration only.
|
|
|
| | | | | |
|
